AIM Specialty Health AIM Specialty Health


Promoting optimal cancer care while reducing costs

Thanks to medical innovation, there are more cancer treatment options than ever before. But research shows that there’s a lot of variation in treatment practice patterns—and costs have never been higher. Each type and stage of cancer has multiple treatment options and there is growing demand for treatments that may lack compelling evidence of clinical superiority, reduced toxicity or cost effectiveness.

Our Oncology Solution is a value-based approach to help drive appropriate patient care with evidence-based medicine and clinical pathways. We address medical and radiation oncology including:

Clinical Appropriateness Review and Pathway Selection for Medical Oncology

  • Complete regimens, not just individual drugs, are reviewed to confirm treatment is evidence-based and dosing is appropriate
  • Offers providers treatment pathways selected based on efficacy, lower toxicity, and cost
  • Enhanced reimbursement for pathway adherence rewards practices for value in cancer care

Clinical Appropriateness Review for Radiation Oncology
Through one integrated platform we automate review of:

  • Intensity Modulated Radiotherapy (IMRT), Proton Beam Therapy, Stereotactic Body Radiation Therapy (SBRT), and Brachytherapy
  • Fraction and hypofractionation to ensure members receive the number of treatments appropriate for their condition
  • Special procedures, consults, positioning aids, and treatment simulations associated with therapy
  • Image Guided Radiation Therapy (IGRT) used in conjunction with external beam treatments